Sitafloxacin for Third-Line <i>Helicobacter pylori</i> Eradication: A Systematic Review
Background and Aim: Sitafloxacin-based therapy is a potent candidate for third-line <i>Helicobacter pylori</i> eradication treatment. In this systematic review, we summarise current reports with sitafloxacin-based therapy as a third-line treatment. Methods: Clinical studies were systemat...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-06-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/10/12/2722 |